MDT referral and review software: Use of the multi-disciplinary team (MDT) meeting software to submit, review and discuss referrals
Study summary
Multi-Disciplinary Team (MDT) meetings are crucial for planning patient care in the National Health Service (NHS), but they can be time-consuming and sometimes lack complete patient information. This can lead to delays in treatment decisions, potentially incomplete care plans, or the need to repeatedly discuss the same patient cases.
This study aims to test a new software called Salutare One Referral. One Referral is designed to make these meetings more efficient and effective. We want to see if this software can help healthcare staff prepare MDT referral information more easily and facilitate a more informed MDT discussion, which could lead to better patient care. If successful, this could help improve how MDTs operate across the NHS.
Eligibility
Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* MDT meeting Panel Members, Coordinators and staff submitting MDT referrals will take part in this study.
Exclusion Criteria:
* MDT meeting Panel Members, Coordinators and staff submitting MDT referrals who are unwilling or unable to take part in the study.
Primary outcome measure(s)
One Referral system safety in facilitating effective MDT meetings — 8 weeks (4 MDT meetings) for complex MDTs or 4 weeks (8 MDT meetings) for high-volume MDTs MDT panel participant feedback on safety and operational incidents
One Referral system implementation feasibility in facilitating effective MDT meetings — 8 weeks (4 MDT meetings) for complex MDTs or 4 weeks (8 MDT meetings) for high-volume MDTs MDT panel participant feedback on effectiveness (non-validated questionnaire)
One Referral system acceptability to MDT panel members acceptability in facilitating — 8 weeks (4 MDT meetings) for complex MDTs or 4 weeks (8 MDT meetings) for high-volume MDTs MDT panel participant feedback on acceptability (Software Usability Scale 0-100, higher score indicate a better outcome)
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.